Mechanism of human MxA protein action: variants with changed antiviral properties

T Zürcher1, J Pavlovic, P Staeheli

  • 1Institute for Immunology and Virology, University of Zürich, Switzerland.

The EMBO Journal
|April 1, 1992
PubMed

Insights

A mutant human MxA protein (MxA(R645)) specifically inhibits influenza virus replication. Its antiviral activity and mechanism depend on cellular location, with nuclear MxA mimicking mouse Mx1 action.

Area of Science:

  • Virology
  • Cell Biology
  • Immunology

Background:

  • Interferon treatment induces Mx proteins that inhibit viral replication.
  • Human MxA is a cytoplasmic protein inhibiting influenza and vesicular stomatitis viruses.
  • Mx proteins can exist in nuclear or cytoplasmic forms with distinct functions.

Purpose of the Study:

  • To characterize a mutant human MxA protein (MxA(R645)) with altered antiviral specificity.
  • To investigate the effect of cellular localization (cytoplasmic vs. nuclear) on MxA's antiviral mechanism.
  • To identify regions of MxA responsible for determining antiviral specificity.

Main Methods:

  • Site-directed mutagenesis to create MxA(R645) mutant.
  • Transfection of cells with wild-type and mutant MxA constructs.
  • Assays to measure inhibition of influenza virus and vesicular stomatitis virus replication.
  • Localization studies using nuclear transport signals.

Main Results:

  • MxA(R645) inhibited influenza virus but not vesicular stomatitis virus, unlike wild-type MxA.
  • In the cytoplasm, MxA(R645) blocked influenza virus post-transcriptionally.
  • When localized to the nucleus, MxA(R645) inhibited influenza virus primary transcription, similar to mouse Mx1.

Conclusions:

  • A specific region near the MxA carboxy terminus dictates its antiviral specificity.
  • Nuclear localization alters MxA's antiviral mechanism, enabling it to inhibit viral transcription.
  • Nuclear MxA can functionally mimic nuclear Mx proteins like mouse Mx1.

Related Concept Videos

Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
DNA Base Pairing02:27

DNA Base Pairing

Erwin Chargaff’s rules on DNA equivalence paved the way for the discovery of base pairing in DNA. Chargaff’s rules state that in a double-stranded DNA molecule,
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...